Charts
18 Apr, 2024
17 Apr, 2024
16 Apr, 2024
15 Apr, 2024
12 Apr, 2024
11:48
Seeking Alpha
11 Apr, 2024
10 Apr, 2024
09 Apr, 2024
08 Apr, 2024
News
08 Apr, 2024
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile app-enabled product for general wellness, Truvaga Plus, which will be available on www.truvaga.com beginning April 8, 2024. Our first general wellness product, Truvaga 350, exceeded our expectations and Truvaga Plus will be an exciting addition to the Truvaga brand. Truvaga Plus is engineer
02 Apr, 2024
electroCore Granted Two New U.S. PatentsROCKAWAY, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO). The two patents were issued on April 2, 2024, and relate to electroCore’s non-invasive vagus nerve stimulation (nVNS) technology: US Patent No. 11,944,815 entitled “Non-Invasive Nerve Sti
16 Mar, 2024
electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript March 13, 2024 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.55. ECOR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the electroCore […]
14 Mar, 2024
Q4 2023 electroCore, Inc. Earnings Call
13 Mar, 2024
electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -10.91% and 0.65%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced fourth quarter and full year 2023 financial results. Fourth Quarter 2023 and Recent Highlights Reported record full year of 2023 revenu
Companies Reporting Before The Bell
• Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share ...
12 Mar, 2024
electroCore (NASDAQ:ECOR) is set to give its latest quarterly earnings report on Wednesday, 2024-03-13. Here's what investors need to ...
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend the 36th Annual Roth Conference taking place at The Ritz Carlton Laguna Niguel in Dana Point, California on March 17 – 19, 2024. electroCore will host 1x1 investor meetings on March 18 and 19, 2024. Please contact Roth MKM to schedule a 1x1 meeting. In addi
05 Mar, 2024
21:05
Yahoo! Finance
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the fourth quarter and year ended December 31, 2023, after the close of the market on Wednesday, March 13, 2024. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions. Wednesday, March 13, 4:30 PM ESTDomestic: 877-407-8835Inter
21 Dec, 2023
In this piece, we will take a look at these stocks under $10 are poised to explode. If you want to skip our introduction to these tricky stocks, jump to These 5 Stocks Under $10 Are Poised To Explode. The US equity markets remain on track for a strong finish in 2023 as major indices […]
12 Dec, 2023
13:00
Yahoo! Finance
ROCKAWAY, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to a system for stimulating a nerve target in the head or neck of a patient for treatment of various disorders, such as primary headache. U.S. Patent No. 11,839,764 entitled “Systems and Methods for Treating a Medical Condition with an Electrical Stimulation Tre
15 Nov, 2023
13:15
Yahoo! Finance
ROCKAWAY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Medical Officer, Dr. Peter Staats will host an analyst day entitled “Accessing the Power of Vagus Nerve Stimulation with gammaCore™” on November 21, 2023 at 1:30pm EST. The webinar will cover the nVNS mechanism of action and potential pipeline of indications using the company’s proprietary nVNS technology plat
09 Nov, 2023
electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript November 8, 2023 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.68 EPS, expectations were $-0.64. Operator: Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call. At this time, all participants on a listen only mode. Please make sure to mute yourself. A […]
08 Nov, 2023
Net Sales Surge by 128% Year-Over-Year; Company Raises Full-Year Revenue Guidance
Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third quarter 2022 Company increases revenue guidance for full year 2023 to $15.0 million - $15.5 million Company to host a conference call and webcast today, November 8, 2023 at 4:30 PM EST ROCKAWAY, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company and wellness company, today announced third quarter 2023 financial results and prov
07 Nov, 2023
13:00
Yahoo! Finance
ROCKAWAY, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, is scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place at the Westin NY Grand Central on November 16, 2023. 1x1 Meetings electroCore will host 1x1 investor meetings on November 16, 2023. Please contact your Canaccord representative to schedul
24 Oct, 2023
12:00
Yahoo! Finance
Clinical Trial suggests nVNS can reduce the use of rescue medications for exacerbations of nausea due to Gastroparesis or Functional Dyspepsia FIGURE 1 Primary Endpoint (n=35): Average number of nausea pills. Overall significance (Type 3 F test): p=0.0007 ROCKAWAY, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced top line data from an abstract being presented as an oral podium presentation at
17 Oct, 2023
12:00
Yahoo! Finance
Extension maintains listing through March 17, 2026ROCKAWAY, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial stage bioelectronic medicine and wellness company, announced today that gammaCore therapy will continue to be listed in the United Kingdom’s National Health Service (NHS) Supply Chain catalogue for an additional two years through March 17, 2026. The listing, which commenced on June 4, 2019, was scheduled to terminate on March 18, 2024. “We are delight
11 Oct, 2023
12:00
Yahoo! Finance
ROCKAWAY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to a treatment protocol for nVNS. U.S. Patent No. 11,779,756 entitled “Systems and Methods for Vagal Nerve Stimulation” was issued on October 10, 2023, and is generally related to a preferable treatment paradigm for nVNS that involves applying a single dose of s
10 Oct, 2023
12:00
Yahoo! Finance
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache Associated with Subarachnoid Hemorrhage (SAH) “NOVIS” Clinical Trial (n=150) of nVNS for the acute treatment of Ischemic Stroke will complete recruitment in 2023 ROCKAWAY, N.J., Oct. 10, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced top line data from two abstracts being presented at the 15th World Stroke
09 Oct, 2023
12:00
Yahoo! Finance
ROCKAWAY, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the third quarter ended September 30, 2023, after the close of the market on Wednesday, November 8, 2023. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions. Wednesday, November 8, 2023, 4:30 PM ESTDomestic: 877-407-8835Inter
05 Sep, 2023
Gainers
Helius Medical Tech (NASDAQ:HSDT) shares increased by 50.5% to $11.11 during Tuesday's pre-market session. The company's market ...
10 Aug, 2023
09 Aug, 2023
20:15
Seeking Alpha
08 Aug, 2023
Gainers
Infinity Pharmaceuticals (NASDAQ:INFI) stock moved upwards by 60.9% to $0.14 during Tuesday's regular session. Trading volume ...
04 Aug, 2023
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...
01 Aug, 2023
27 Jul, 2023
Gainers
SIGA Technologies (NASDAQ:SIGA) stock increased by 21.8% to $6.2 during Thursday's after-market session. This security traded ...
11 Jul, 2023
06 Jul, 2023
14:21
FinancialContent
electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a ...
11 May, 2023
electroCore (NASDAQ:ECOR) brought in sales totaling $2.78 million during Q1 according to data provided by Benzinga Pro. However, ...
04 May, 2023
03 May, 2023
electroCore (NASDAQ:ECOR) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:00 PM.
Here's what investors need to know ...
02 May, 2023
17 Apr, 2023
24 Mar, 2023
Gainers
electroCore (NASDAQ:ECOR) shares increased by 27.9% to $5.47 during Friday's regular session. As of 13:30 EST, electroCore's ...
16 Mar, 2023
Gainers
Lipella Pharmaceuticals (NASDAQ:LIPO) stock increased by 48.4% to $2.71 during Thursday's pre-market session. The market value ...
09 Mar, 2023
08 Mar, 2023
Companies Reporting Before The Bell
• Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on ...
07 Mar, 2023
28 Feb, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell.
The post 7 Stocks to Sell as Borrowing Costs Rise appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
It doesn’t matter if you have $500 or $5 million. Do this now.
Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
27 Feb, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move.
High ...
13 Feb, 2023
Gainers
Tenon Medical (NASDAQ:TNON) stock moved upwards by 7.7% to $1.19 during Monday's after-market session. The company's market cap ...
17 Jan, 2023
18:21
FinancialContent
Gainers
Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided ...
13 Jan, 2023
Upgrades
For OrganiGram Holdings Inc (NASDAQ:OGI), Stifel upgraded the previous rating of Hold to Buy. In the first quarter, OrganiGram ...
11 Jan, 2023
Gainers
Yield10 Bioscience (NASDAQ:YTEN) shares increased by 59.5% to $3.35 during Wednesday's after-market session. This security ...
30 Dec, 2022
Gainers
Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday's after-market session. The market value of their outstanding ...
20 Dec, 2022
Gainers
Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock moved upwards by 17.0% to $0.67 during Tuesday's after-market session. The market ...
13:29
Seeking Alpha
01 Dec, 2022
18:33
FinancialContent
Gainers
Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24.
Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
The ...
28 Nov, 2022
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When ...
22 Nov, 2022
15:47
FinancialContent
The Nasdaq Composite closed lower by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider ...
17 Nov, 2022
Gainers
Ardelyx (NASDAQ:ARDX) shares moved upwards by 53.3% to $1.87 during Thursday's regular session. Trading volume for Ardelyx's ...
16 Nov, 2022
The Dow Jones gained by over 50 points on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders ...
11 Nov, 2022
14:18
FinancialContent
The Dow Jones jumped by over 1,200 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders ...
07 Nov, 2022
08:07
FinancialContent
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) shares surged 105.8% to close at $7.82 on Friday. Peak Bio reported closing of up to $100 ...
06 Nov, 2022
04 Nov, 2022
16:54
FinancialContent
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) jumped 115% to $8.17. Peak Bio reported closing of up to $100 million common stock purchase ...
Gainers
Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on ...
03 Nov, 2022
02 Nov, 2022
17:28
FinancialContent
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Benefitfocus, Inc. (NASDAQ: ...
17 Oct, 2022
10:00
FinancialContent
Pre-open movers
U.S. stock futures traded higher in early pre-market trade on Monday after closing lower in the previous session. ...
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as ...
14 Oct, 2022
21 Sep, 2022
16 Sep, 2022
For years, technology has been key to enhancing soldiers’ tactical ability by helping administer fast and effective medical care ...
23 Aug, 2022
According to data from Benzinga Pro, during Q2, electroCore's (NASDAQ:ECOR) reported sales totaled $2.16 million. Despite a 4.39% ...
07 Aug, 2022
04 Aug, 2022
electroCore (NASDAQ:ECOR) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here's what investors need to know ...
03 Aug, 2022
12 Jul, 2022
23 Jun, 2022
06 Jun, 2022
Gainers
DiDi Global Inc. (NYSE: DIDI) rose 52.4% to $2.82 in pre-market trading following Wall Street Journal report indicating ...
03 Jun, 2022
Gainers
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) shares gained 47.5% to settle at $0.8436 on Thursday. Based on the review of ...
02 Jun, 2022
Gainers
Repare Therapeutics Inc. (NASDAQ: RPTX) jumped 38.1% to $12.08 after the company announced it has entered into a worldwide ...
Gainers
Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
Spark Networks SE (NASDAQ: LOV) jumped ...
18 May, 2022
Gainers
Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises ...
13 Apr, 2022
11:26
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!
The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace.
More From InvestorPlace
Stock Prodigy Who Found NIO at $2… Says Buy THIS
It doesn’t matter if you have $500 in savings or $5 million. Do this now.
10 Stocks Are Issuing Sell Signals
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
07 Apr, 2022
